drugset / Press release
MacroGenics Announces Continuation of SOPHIA Study of Margetuximab Based on Completion of Interim Futility Analysis
2018-01-23 · MacroGenics · original macrogenics.com ↗
MacroGenics Announces Continuation of SOPHIA Study of Margetuximab Based on Completion of Interim Futility Analysis 14.3 KB
The release as fetched from its publisher. macrogenics.com ↗